Trulicity 0.75mg Injection

Trulicity 0.75mg Injection contains active component Dulaglutide. It is a medication that is used to treat type 2 diabetes. It belongs to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Trulicity 0.75mg Injection works by mimicking the action of a hormone called glucagon-like peptide-1 (GLP-1) in the body. It is typically used in combination with other diabetes medications, such as metformin or sulfonylureas, when diet and exercise alone are not sufficient to control blood sugar levels. This medication improves glycemic control and helps prevent hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar). Many people with type 2 diabetes struggle with weight management. This medication has been shown to promote weight loss or maintenance in some individuals. This can benefit overall health and contribute to better diabetes management.

It is administered once a week, making it a convenient treatment option compared to medications that require daily dosing. This can simplify the medication regimen for individuals with diabetes and improve treatment adherence. Trulicity 0.75mg Injection is contraindicated in individuals with known hypersensitivity or allergic reactions to it or its components. This medication should be avoided in individuals with a personal or family history of MTC (medullary thyroid cancer), a type of thyroid cancer. Tell your doctor if you have a history of pancreatic, eye, or kidney problems. The safety and efficacy in children and adolescents under the age of 18 have not been established. Therefore, Trulicity 0.75mg Injection is not recommended for use in this population.